← Back to Vaccine Database

Dendritic cell vaccine AV-COVID-19

Live attenuated vaccine · VDDBV0204

Target & Classification

SARS-CoV-2SARS-CoV-2
Live attenuated vaccine
HIV Infections; COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials8

NCT IDPhaseDisease / Condition
NCT02766049 Phase 2HIV Infections
NCT02767193 Phase 1HIV Infections
NCT00796770 Phase 1HIV Infections
NCT00402142 Phase 2HIV Infections
NCT04690387 Phase 1COVID-19
NCT04685603 Phase 1COVID-19
NCT04386252 Phase 2COVID-19
NCT05007496 Phase 2COVID-19